IDEAYA Biosciences (IDYA) Enterprise Value (2018 - 2026)

IDEAYA Biosciences has disclosed Enterprise Value across 9 years of filings, most recently posting -$671.2 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$671.2 million, up 3.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$671.2 million (up 3.08% YoY), and the FY2025 annual result was -$639.4 million, up 5.46% from the prior year.
• Enterprise Value came in at -$671.2 million for Q1 2026 at IDEAYA Biosciences, down from -$639.4 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$252.6 million in Q1 2022 to a low of -$920.0 million in Q3 2024.
• The 5-year median for Enterprise Value is -$639.4 million (2025), against an average of -$562.1 million.
• Across the five-year window, Enterprise Value advanced 16.45% in 2022 and slumped 105.84% in 2024, its largest moves.
• IDEAYA Biosciences' Enterprise Value stood at -$364.8 million in 2022, then plunged by 43.93% to -$525.1 million in 2023, then declined by 28.79% to -$676.3 million in 2024, then climbed by 5.46% to -$639.4 million in 2025, then decreased by 4.98% to -$671.2 million in 2026.
• The last three Enterprise Value figures came in at -$671.2 million (Q1 2026), -$639.4 million (Q4 2025), and -$786.9 million (Q3 2025), per Business Quant data.